ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.00%
US Tech 100
18,237.60
0.03%
S&P 500
5,320.48
-0.02%
US Dollar vs CAD
1.36631
0.16%
Bitcoin
69,515.06
-0.88%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BioCardia Inc (BCDA)

  7. BioCardia Inc (BCDA) News

BCDA

BioCardia (BCDA)

BioCardia Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCDA
DateTimeSourceHeadlineSymbolCompany
05/21/20244:00PMGlobeNewswire Inc.BioCardia Announces Reverse Stock SplitNASDAQ:BCDABioCardia Inc
05/14/20243:02PMGlobeNewswire Inc.BioCardia Reports First Quarter 2024 Business Highlights and Financial ResultsNASDAQ:BCDABioCardia Inc
05/01/20246:00AMGlobeNewswire Inc.BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important OutcomesNASDAQ:BCDABioCardia Inc
04/25/20248:00AMGlobeNewswire Inc.BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In CohortNASDAQ:BCDABioCardia Inc
03/27/20243:00PMGlobeNewswire Inc.BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial ResultsNASDAQ:BCDABioCardia Inc
03/20/20246:00AMGlobeNewswire Inc.BioCardia to Host 2023 Financial Results and Corporate Update Conference Call on March 27, 2024NASDAQ:BCDABioCardia Inc
03/13/20246:00AMGlobeNewswire Inc.BioCardia and StemCardia Announce Biotherapeutic Delivery PartnershipNASDAQ:BCDABioCardia Inc
03/12/20246:00AMGlobeNewswire Inc.BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure StudyNASDAQ:BCDABioCardia Inc
03/04/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
03/04/20247:00AMGlobeNewswire Inc.BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart FailureNASDAQ:BCDABioCardia Inc
02/27/20243:53PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCDABioCardia Inc
02/15/20246:00AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCDABioCardia Inc
02/14/20244:06PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCDABioCardia Inc
02/14/20243:17PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCDABioCardia Inc
02/09/20248:58AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
02/08/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
02/08/20246:00AMGlobeNewswire Inc.BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDANASDAQ:BCDABioCardia Inc
02/06/20243:28PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCDABioCardia Inc
02/02/20241:06PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BCDABioCardia Inc
01/31/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
01/31/20246:00AMGlobeNewswire Inc.BioCardia Announces Two Scientific Abstracts Have Been Accepted at the 2024 Technology and Heart Failure Therapeutics ConferenceNASDAQ:BCDABioCardia Inc
01/03/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
01/03/20246:00AMGlobeNewswire Inc.BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for ShareholdersNASDAQ:BCDABioCardia Inc
12/19/20236:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
12/19/20236:00AMGlobeNewswire Inc.BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection FractionNASDAQ:BCDABioCardia Inc
12/18/20236:16AMGlobeNewswire Inc.BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation MinutesNASDAQ:BCDABioCardia Inc
12/18/20236:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
12/06/20235:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCDABioCardia Inc
12/06/20235:03AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCDABioCardia Inc
12/05/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCDABioCardia Inc
 Showing the most relevant articles for your search:NASDAQ:BCDA

Your Recent History

NASDAQ
ONEW
OneWater Marine
BIT
F15815
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved